NuvoBio
PrivateLast Round
Accelerator
Mar 13, 2026
Total Funding Raised
$173,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NuvoBio is a drug discovery company that develops a bio-medical technology platform designed to expedite the development of peptide therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuvoBio Comparables
Compare NuvoBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProteinQure | 90% | |
| Alcamena Stem Cell Therapeutics | 86% | |
| Menten AI | 85% | |
NuvoBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 13, 2026 | ||||
| Grant | Dec 3, 2024 | ||||
| Accelerator | May 1, 2024 |
Key People
Founding team and executive leadership
NuvoBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Economic Development Agency for Southern Ontario | Grant |
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Creative Destruction Lab | Accelerator |
| Capital BioVentures | Grant |
| Merck Digital Sciences Studio | Accelerator |
| The Venture Collective | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 406% MoM to 1.3K.
- Mar 13, 2026
$100K raised, led by Merck Digital Sciences Studio.
NuvoBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NuvoBio's valuation, stock price, and market status.